These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8052597)

  • 41. Kinetic studies of rat kidney gamma-glutamyltranspeptidase deacylation reveal a general base-catalyzed mechanism.
    Castonguay R; Lherbet C; Keillor JW
    Biochemistry; 2003 Oct; 42(39):11504-13. PubMed ID: 14516202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insights into the catalytic mechanism of human sEH phosphatase by site-directed mutagenesis and LC-MS/MS analysis.
    Cronin A; Homburg S; Dürk H; Richter I; Adamska M; Frère F; Arand M
    J Mol Biol; 2008 Nov; 383(3):627-40. PubMed ID: 18775727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Off-the-shelf proteins that rival tailor-made antibodies as catalysts.
    Hollfelder F; Kirby AJ; Tawfik DS
    Nature; 1996 Sep; 383(6595):60-2. PubMed ID: 8779715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Catalytic mechanism of scytalone dehydratase: site-directed mutagenisis, kinetic isotope effects, and alternate substrates.
    Basarab GS; Steffens JJ; Wawrzak Z; Schwartz RS; Lundqvist T; Jordan DB
    Biochemistry; 1999 May; 38(19):6012-24. PubMed ID: 10320327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of changes in three catalytic residues on the relative stabilities of some of the intermediates and transition states in the citrate synthase reaction.
    Kurz LC; Nakra T; Stein R; Plungkhen W; Riley M; Hsu F; Drysdale GR
    Biochemistry; 1998 Jul; 37(27):9724-37. PubMed ID: 9657685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression improvement and mechanistic study of the retro-Diels-Alderase catalytic antibody 10F11 by site-directed mutagenesis.
    Zheng L; Goddard JP; Baumann U; Reymond JL
    J Mol Biol; 2004 Aug; 341(3):807-14. PubMed ID: 15288788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nucleophilic and general acid catalysis at physiological pH by a designed miniature esterase.
    Nicoll AJ; Allemann RK
    Org Biomol Chem; 2004 Aug; 2(15):2175-80. PubMed ID: 15280952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enzymatic characterization of glycosidase antibodies raised against a chair transition state analog and the retained catalytic activity from the expressed single chain antibody fragments.
    Choi SO; Youn HJ; Yu J
    Mol Cells; 2002 Jun; 13(3):463-9. PubMed ID: 12132587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. X-ray, NMR, and mutational studies of the catalytic cycle of the GDP-mannose mannosyl hydrolase reaction.
    Gabelli SB; Azurmendi HF; Bianchet MA; Amzel LM; Mildvan AS
    Biochemistry; 2006 Sep; 45(38):11290-303. PubMed ID: 16981689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thiol ester hydrolysis catalyzed by glutathione S-transferase A1-1.
    Dietze EC; Grillo MP; Kalhorn T; Nieslanik BS; Jochheim CM; Atkins WM
    Biochemistry; 1998 Oct; 37(42):14948-57. PubMed ID: 9778372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydrolytic antibodies: variations on a theme.
    MacBeath G; Hilvert D
    Chem Biol; 1996 Jun; 3(6):433-45. PubMed ID: 8807874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
    Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW
    Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A catalytic antibody programmed for torsional activation of amide bond hydrolysis.
    Aggarwal R; Benedetti F; Berti F; Buchini S; Colombatti A; Dinon F; Galasso V; Norbedo S
    Chemistry; 2003 Jul; 9(13):3132-42. PubMed ID: 12833295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interplay between binding energy and catalysis in the evolution of a catalytic antibody.
    Ulrich HD; Mundorff E; Santarsiero BD; Driggers EM; Stevens RC; Schultz PG
    Nature; 1997 Sep; 389(6648):271-5. PubMed ID: 9305839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design of biomimetic catalysts by molecular imprinting in synthetic polymers: the role of transition state stabilization.
    Wulff G; Liu J
    Acc Chem Res; 2012 Feb; 45(2):239-47. PubMed ID: 21967389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-secondary and solvent deuterium kinetic isotope effects on beta-lactamase catalysis.
    Adediran SA; Deraniyagala SA; Xu Y; Pratt RF
    Biochemistry; 1996 Mar; 35(11):3604-13. PubMed ID: 8639512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis.
    Denu JM; Lohse DL; Vijayalakshmi J; Saper MA; Dixon JE
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2493-8. PubMed ID: 8637902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of covalent binding antibodies.
    Armentano F; Knight T; Makker S; Tramontano A
    Immunol Lett; 2006 Feb; 103(1):51-7. PubMed ID: 16297987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.